LONDON, UK: bioMérieux SA, a world leader in the field of in vitro diagnostics (“IVD”), has announced that it is making an immediate £70M investment in Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of nanopore-based molecular sensing technology. The investment will give bioMérieux a 3.5% stake in Oxford Nanopore, with…
Tag: Mayo Clinic
Imaging Biometrics and Mayo Clinic enter into an agreement to develop IB Trax
LONDON: Imaging Biometrics LLC (IB), has entered into an agreement with Mayo Clinic to develop a brain lesion tracking platform, IB Trax, a news release said. The collaboration’s objective is the development of an innovative AI technology to track metastatic and primary brain tumours. IB’s proven quantitative technologies will form the foundation of IB Trax…